Lucy Lin
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
Papers in
-
- Botulinum Toxin and Related Neurological Disorders 7
- Neurological diseases and metabolism 5
- Neurological disorders and treatments 3
-
- CRISPR and Genetic Engineering 1
- Co-authors
- Robert Förster (3 shared papers)Gerolf Gros (2 shared papers)Kim D. Janda (10 shared papers)Yūichi Ono (2 shared papers)Xiao Yu Wu (2 shared papers)Jason Li (2 shared papers)Andrew M. Rauth (2 shared papers)Ping Cai (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)RSC Medicinal Chemistry (2 papers)ACS Infectious Diseases (2 papers)Beilstein Journal of Organic Chemistry (1 paper)Chemical Research in Toxicology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Lucy Lin
20 papers receiving 441 citations
Peers
Comparison fields: 5 of 92
- Biomaterials 68
- Neurology 54
- Cellular and Molecular Neuroscience 63
- Neurology 27
- Toxicology 10
Countries citing papers authored by Lucy Lin
This map shows the geographic impact of Lucy Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Lin more than expected).
Fields of papers citing papers by Lucy Lin
This network shows the impact of papers produced by Lucy Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Lin. The network helps show where Lucy Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 89 | |
| 2 | 1998 | 64 | |
| 3 | 1986 | 41 | |
| 4 | 1976 | 39 | |
| 5 | 2017 | 36 | |
| 6 | 2005 | 27 | |
| 7 | 2019 | 25 | |
| 8 | 2019 | 23 | |
| 9 | 2018 | 22 | |
| 10 | 2006 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2018 | 14 | |
| 13 | 2021 | 11 | |
| 14 | 1997 | 8 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2022 | 2 |
About Lucy Lin
Lucy Lin is a scholar working on Neurology, Molecular Biology, Cellular and Molecular Neuroscience, Neurology and Organic Chemistry, having authored 20 papers that have together received 459 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (7 papers), Neurological diseases and metabolism (5 papers), Hereditary Neurological Disorders (3 papers), Neurological disorders and treatments (3 papers), Hemoglobin structure and function (2 papers), CRISPR and Genetic Engineering (1 paper), Traditional and Medicinal Uses of Annonaceae (1 paper) and Chemical synthesis and alkaloids (1 paper). The work is most often cited by research in Biomaterials (68 citations), Neurology (54 citations), Cellular and Molecular Neuroscience (63 citations), Neurology (27 citations) and Toxicology (10 citations). Lucy Lin has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert Förster, Gerolf Gros, Kim D. Janda, Yūichi Ono, Xiao Yu Wu, Jason Li, Andrew M. Rauth, Ping Cai, Azhar Z. Abbasi and Chunsheng He. Their work appears in journals such as Journal of Medicinal Chemistry, RSC Medicinal Chemistry, ACS Infectious Diseases, Beilstein Journal of Organic Chemistry and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.